FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Corrado Tarella

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Hematopoietic Stem Cells

Co-author Network

Publications

TOP 3
Angela Gueli; Huijing Hu; Irene Ricca; Alberto De Crescenzo; Daniela Gottardi; Corrado Tarella
Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
Pier Luigi Zinzani; Giovanni Barosi; Atto Billio; Angelo Michele Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Luigi Rigacci; Corrado Tarella; Sante Tura; Umberto Vitolo
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
Carlo Maria Fronticelli Baldelli; Manuela Monni; Paola Omedè; Roberto Passera; Marco Ruella; Stefano Scuderi; Corrado Tarella
A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Corrado Tarella (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Angela Gueli; Huijing Hu; Irene Ricca; Alberto De Crescenzo; Daniela Gottardi; Corrado Tarella
Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
Blood transfusion = Trasfusione del sangue 2013;11(2):311-4.
2013: Pier Luigi Zinzani; Giovanni Barosi; Atto Billio; Angelo Michele Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Luigi Rigacci; Corrado Tarella; Sante Tura; Umberto Vitolo
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
American journal of hematology 2013;88(3):185-92.
2012: Carlo Maria Fronticelli Baldelli; Manuela Monni; Paola Omedè; Roberto Passera; Marco Ruella; Stefano Scuderi; Corrado Tarella
A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept.
Cytotherapy 2012;14(9):1101-9.
2012: Anna Guidetti; Rodolfo Lanocita; Silvia L Locatelli; Walter Malorni; Alfonso Marchianò; Paola Matteucci; Roberta Mortarini; Marina Pierdominici; Corrado Tarella; Andrea Anichini; Cristiana Barbati; Carmelo Carlo-Stella; Paolo Corradini; Lilli Devizzi; Massimo Di Nicola; Anna Dodero; Lucia Farina; Alessandro M Gianni
Phase II study of sorafenib in patients with relapsed or refractory lymphoma.
British journal of haematology 2012;158(1):108-19.
2012: P Sivera; Angela Gueli; Huijing Hu; Marco Ruella; Muhamed Wade; Corrado Tarella
Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2012;23(4):331-4.
2012: Guglielmo Mario Actis Dato; S Del Ponte; Roberto Flocco; Piero Forsennati; Paola Omedé; Francesco Parisi; G Punta; Fabrizio Sansone; Gian Luca Bardi; Riccardo Casabona; Edoardo Zingarelli; Corrado Tarella
Preoperative mobilization of bone marrow-derived cells followed by revascularization surgery: early and long-term outcome.
The International journal of artificial organs 2012;35(1):67-76.
2011: stefano buttiglieri; Alessandra Risso; Marco Ruella; Lorenzo Silengo; Tiziana Spatola; enrico vittorio avvedimento; Corrado Tarella
The aging effect of chemotherapy on cultured human mesenchymal stem cells.
Experimental hematology 2011;39(12):1171-81.
2011: Anna Guidetti; Silvia L Locatelli; Luigi Mariani; Rosalba Miceli; Roberto Passera; Alessandra Risso; Marco Ruella; Corrado Tarella; Adele Testi; stefano buttiglieri; Carmelo Carlo-Stella; liliana devizzi; Massimo Di Nicola; Arianna Giacomini; Alessandro M Gianni
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia.
Cancer 2011;117(22):5074-84.
2011: Pierfrancesco Franco; Agnieszka Namysl-Kaletka; Corrado Tarella; Angela Botticella; Patrizia Ciammella; Alberto De Crescenzo; Andrea Riccardo Filippi; Umberto Ricardi
Primary duodenal follicular lymphoma: 6-years complete remission after combined radio-immunotherapy.
Acta gastro-enterologica Belgica 2011;74(2):337-42.
2011: Corrado Tarella; Roberto Passera; Michele Magni; Fabio Benedetti; Andrea Rossi; Angela Gueli; Caterina Patti; Guido Parvis; Fabio Ciceri; Andrea Gallamini; Sergio Cortelazzo; Valerio Zoli; Paolo Corradini; Alessandra Carobbio; Antonino Mulé; Marco Bosa; Anna Barbui; Massimo Di Nicola; Marco Sorio; Daniele Caracciolo; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(7):814-24.
2011: Adriano Chio; Gabriele Mora; Vincenzo La Bella; Claudia Caponnetto; Gianluigi Mancardi; Mario Sabatelli; Gabriele Siciliano; Vincenzo Silani; Massimo Corbo; Cristina Moglia; Andrea Calvo; Roberto Mutani; Sergio Rutella; Francesca Gualandi; Mario Melazzini; Rosanna Scimè; Mario Petrini; Paola Bondesan; Silvia Garbelli; Stefania Mantovani; Caterina Bendotti; Corrado Tarella
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.
Muscle & nerve 2011;43(2):189-95.
2010: Luca Besso; Alessandro Domenico Quercia; Germana Daidola; Manuel Burdese; Loredana Colla; Elisa Basso; Eirini Karvela; Cristina Marcuccio; Corrado Tarella; Giuseppe Paolo Segoloni
[Lymphomatous renal involvement].
Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia 2010;27 Suppl 50():S34-9.
2010: M Ruella; Alberto Rocci; Irene Ricca; C Carniti; C Labetti Bodoni; marco ladetto; Daniele Caracciolo; Mario Boccadoro; Carmelo Carlo-Stella; Paolo Corradini; Corrado Tarella
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.
Bone marrow transplantation 2010;45(3):505-12.
2010: Corrado Tarella; Sergio Rutella; Francesca Gualandi; Mario Melazzini; Rosanna Scimè; Mario Petrini; Cristina Moglia; Marco Ulla; Paola Omedé; Vincenzo La Bella; Massimo Corbo; Vincenzo Silani; Gabriele Siciliano; Gabriele Mora; Claudia Caponnetto; Mario Sabatelli; Adriano Chio
Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.
Cytotherapy 2010;12(1):50-9.
2009: Michele Magni; Massimo Di Nicola; Carmelo Carlo-Stella; Paola Matteucci; liliana devizzi; Corrado Tarella; Fabio Benedetti; Maurizio Martelli; Caterina Patti; Guido Parvis; Alessandro Rambaldi; T Barbui; ALESSANDRO MASSIMO GIANNI
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
Bone marrow transplantation 2009;43(6):509-11.
2008: liliana devizzi; Anna Guidetti; Corrado Tarella; Michele Magni; Paola Matteucci; Ettore Seregni; Carlo Chiesa; Emilio Bombardieri; Massimo Di Nicola; Carmelo Carlo-Stella; ALESSANDRO MASSIMO GIANNI
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5175-82.
2008: Corrado Tarella; Manuela Zanni; Michele Magni; Fabio Benedetti; Caterina Patti; Tiziano Barbui; Alessandro Pileri; Mario Boccadoro; Fabio Ciceri; Andrea Gallamini; Sergio Cortelazzo; Ignazio Majolino; Salvo Mirto; Paolo Corradini; Roberto Passera; Giovanni Pizzolo; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3166-75.
2008: marco ladetto; Federica De Marco; Fabio Benedetti; Umberto Vitolo; Caterina Patti; Alessandro Rambaldi; Alessandro Pulsoni; Maurizio Musso; Anna Marina Liberati; Attilio Olivieri; Andrea Gallamini; Enrico Pogliani; Vincenzo Callea; Francesco Di Raimondo; Vincenzo Pavone; Alessandra Tucci; Sergio Cortelazzo; Alessandro Levis; Mario Boccadoro; Ignazio Majolino; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Roberto Passera; Paolo Corradini; Corrado Tarella; Delia Rota Scalabrini
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage.
Blood 2008;111(8):4004-13.
2007: Andrea Riccardo Filippi; Pierfrancesco Franco; Carlo Marinone; Corrado Tarella; Umberto Ricardi
Treatment options in skeletal localizations of hairy cell leukemia: a systematic review on the role of radiation therapy.
American journal of hematology 2007;82(11):1017-21.
2007: Paolo Corradini; Anna Dodero; Lucia Farina; Renato Fanin; Francesca Patriarca; Rosalba Miceli; Paola Matteucci; Marco Bregni; Rosanna Scimè; Franco Narni; Enrico Pogliani; Anna Locasciulli; Raffaella Milani; C Carniti; Andrea Bacigalupo; Alessandro Rambaldi; Francesca Bonifazi; Attilio Olivieri; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome.
Leukemia 2007;21(11):2316-23.
2007: Andrea Gallamini; Francesco Zaja; Caterina Patti; Atto Billio; Maria Rosaria Specchia; Alessandra Tucci; Alessandro Levis; Annunziata Manna; Vicenzo Secondo; Luigi Rigacci; Antonello Pinto; Emilio Iannitto; Valerio Zoli; Pierfederico Torchio; Stefano Pileri; Corrado Tarella
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.
Blood 2007;110(7):2316-23.
2007: Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Roberta Calvi; Alessandra Pescarollo; Valerio Zoli; A Fornari; Domenico Novero; Antonello Cabras; M Stella; A Comino; Daniele Remotti; Maurilio Ponzoni; Daniele Caracciolo; marco ladetto; Michele Magni; liliana devizzi; Rosalba Rosato; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvatore Mirto; ALESSANDRO MASSIMO GIANNI
Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
Leukemia 2007;21(8):1802-11.
2007: Alberto Rocci; Irene Ricca; Chiara Dellacasa; Paolo Longoni; Mara Compagno; Roberto Maurizio Francese; Chiara Lobetti Bodoni; Paola Manzini; Daniele Caracciolo; Mario Boccadoro; Dario Ferrero; marco ladetto; Carmelo Carlo-Stella; Corrado Tarella
Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir.
Experimental hematology 2007;35(4):673-81.
2007: Irene Ricca; Alberto Rocci; Daniela Drandi; Roberto Maurizio Francese; Mara Compagno; C Lobetti Bodoni; Federica De Marco; Monica Astolfi; Luigia Monitillo; Sonia Vallet; Roberta Calvi; F Ficara; Paola Omedè; Rosalba Rosato; Andrea Gallamini; Carlo Marinone; Luciana Bergui; Mario Boccadoro; Corrado Tarella; marco ladetto
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.
Leukemia 2007;21(4):697-705.
2006: marco ladetto; Michele Magni; Gloria Pagliano; Federica De Marco; Daniela Drandi; Irene Ricca; Monica Astolfi; Paola Matteucci; Anna Guidetti; Barbara Mantoan; Chiara Lobetti Bodoni; Manuela Zanni; Mario Boccadoro; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1270-6.
2006: marco ladetto; Barbara Mantoan; Federica De Marco; Daniela Drandi; Chiara Aguzzi; Monica Astolfi; Sonia Vallet; Irene Ricca; Maria Dell' Aquila; Gloria Pagliano; Luigia Monitillo; Berardino Pollio; Loredana Santo; Carmen Cristiano; Alberto Rocci; Roberto Maurizio Francese; Chiara Lobetti Bodoni; Alessandra Borchiellini; Piercarla Schinco; Mario Boccadoro; Corrado Tarella
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations.
Experimental hematology 2006;34(12):1680-6.
2006: marco ladetto; Sonia Vallet; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Vincenzo Callea; Caterina Patti; Paolo Coser; Alessio Perrotti; M Sorio; Carola Boccomini; Alessandro Pulsoni; Caterina Stelitano; Rosanna Scimè; Mario Boccadoro; Rosalba Rosato; Federica De Marco; Manuela Zanni; Paolo Corradini; Corrado Tarella
Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial.
Leukemia 2006;20(10):1840-7.
2006: Paolo Corradini; Corrado Tarella; Francesco Zallio; Anna Dodero; Manuela Zanni; Pinuccia Valagussa; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi; T Barbui; Sergio Cortelazzo
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.
Leukemia 2006;20(9):1533-8.
2006: Silvia Gaia; Antonina Smedile; Paola Omedè; Antonella Olivero; Fiorella Sanavio; Federico Balzola; Antonio Ottobrelli; Maria Lorena Abate; Angelo V Marzano; Mario Rizzetto; Corrado Tarella
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.
Journal of hepatology 2006;45(1):13-9.
2006: Stefania Bruno; Benedetta Bussolati; Paolo Scacciatella; Sebastiano Marra; Fiorella Sanavio; Corrado Tarella; Giovanni Camussi
Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction.
Cytokine 2006;34(1-2):56-65.
2006: Sebastiano Marra; Paolo Scacciatella; Tullio Usmiani; Maurizio D'Amico; Mauro Giorgi; Monica Andriani; Massimo Baccega; Mario Boccadoro; Paola Omedè; Fiorella Sanavio; Corrado Tarella
Concurrent G-CSF and GM-CSF administration for the induction of bone marrow-derived cell mobilization in patients with acute myocardial infarction: a pilot study evaluating feasibility, safety and efficacy.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2006;1(4):425-31.
2006: Ignazio Majolino; marco ladetto; Anna Locasciulli; Daniela Drandi; Fabio Benedetti; Andrea Gallamini; Teodoro Chisesi; Angelo De Blasio; Mario Boccadoro; Corrado Tarella
High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission.
Medical oncology (Northwood, London, England) 2006;23(3):359-68.
2006: Giovanni Barosi; Angelo Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Corrado Tarella; Umberto Vitolo; Pier Luigi Zinzani; Sante Tura
Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2006;91(1):96-103.
2005: Paolo Corradini; Francesco Zallio; J Mariotti; Lucia Farina; Marco Bregni; Pinuccia Valagussa; Fabio Ciceri; Andrea Bacigalupo; Anna Dodero; Moira Lucesole; Francesca Patriarca; Alessandro Rambaldi; Rosanna Scimè; Anna Locasciulli; Giuseppe Bandini; ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Attilio Olivieri
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6690-8.
2005: Giovanni Barosi; Angelo Carella; Mario Lazzarino; Monia Marchetti; Maurizio Martelli; Alessandro Rambaldi; Corrado Tarella; Umberto Vitolo; Pier Luigi Zinzani; Sante Tura
Management of nodal indolent (non marginal-zone) non-Hodgkin's lymphomas: practice guidelines from the Italian Society of Hematology, Italian Society of Experimental Hematology and Italian Group for Bone Marrow Transplantation.
Haematologica 2005;90(9):1236-57.
2005: Andrea D Manazza; Lisa Bonello; Marco Pagano; Luigi Chiusa; Domenico Novero; Alessandra Stacchini; Giuseppe Martini; Umberto Vitolo; Corrado Tarella; Giorgio Inghirami; Giorgio Palestro; Roberto Chiarle
Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.
American journal of clinical pathology 2005;124(2):182-90.
2005: Irene Ricca; Mara Compagno; marco ladetto; Alberto Rocci; Maria Dell'Aquila; Paola Omedè; Federica De Marco; SERGIO D'ANTICO; Daniele Caracciolo; Dario Ferrero; Carmelo Carlo-Stella; Corrado Tarella
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.
Leukemia 2005;19(4):644-51.
2005: Corrado Tarella; ALESSANDRO MASSIMO GIANNI
Bone marrow transplantation for lymphoma CR1.
Current opinion in oncology 2005;17(2):99-105.
2005: Corrado Tarella; Davide Bono; Manuela Zanni; Irene Ricca; Daniele Caracciolo
Intensive chemotherapy in patients with lymphoma. Management of the risk of hyperuricemia.
Contributions to nephrology 2005;147():93-104.
2004: marco ladetto; Mara Compagno; Irene Ricca; Marco Pagano; Alberto Rocci; Monica Astolfi; Daniela Drandi; Paola Francia di Celle; Maria Dell'Aquila; Barbara Mantoan; Sonia Vallet; Gloria Pagliano; Federica De Marco; Roberto Maurizio Francese; Loredana Santo; Alessandra Cuttica; Carlo Marinone; Mario Boccadoro; Corrado Tarella
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders.
Blood 2004;103(12):4644-9.
2004: Paolo Corradini; Anna Dodero; Francesco Zallio; Daniele Caracciolo; Marco Casini; Marco Bregni; Franco Narni; Francesca Patriarca; Mario Boccadoro; Fabio Benedetti; Alessandro Rambaldi; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(11):2172-6.
2004: Paolo Corradini; marco ladetto; Francesco Zallio; Monica Astolfi; Elena Rizzo; Selina Sametti; Alessandra Cuttica; Rosalba Rosato; Lucia Farina; Mario Boccadoro; Fabio Benedetti; Alessandro Pileri; Corrado Tarella
Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1460-8.
2004: Giuseppe Todeschini; S Secchi; Enrica Morra; Umberto Vitolo; Ester Orlandi; Felice Pasini; Eugenio Gallo; Achille Ambrosetti; Cristina Tecchio; Corrado Tarella; Attilio Gabbas; Andrea Gallamini; Livio Gargantini; Michele Pizzuti; Giuseppe Fioritoni; L Gottin; G Rossi; Mario Lazzarino; Fabio Menestrina; Marco Paulli; M Palestro; Maria Giuseppina Cabras; Francesco Di Vito; Giovanni Pizzolo
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
British journal of cancer 2004;90(2):372-6.
2003: marco ladetto; Barbara Mantoan; Irene Ricca; Monica Astolfi; Daniela Drandi; Mara Compagno; Sonia Vallet; Maria Dell'Aquila; Alda Alfarano; Paola Rossatto; Alberto Rocci; Umberto Vitolo; Paolo Corradini; Mario Boccadoro; Corrado Tarella
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone.
Experimental hematology 2003;31(9):784-8.
2003: Alessandra Cuttica; Francesco Zallio; marco ladetto; Massimo Di Nicola; Daniele Caracciolo; Michele Magni; Carlo Marinone; Maria Dell'Aquila; Michela Rosace; Alessandro Pileri; Mario Boccadoro; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.
Cancer 2003;98(5):983-92.
2003: ALESSANDRO MASSIMO GIANNI; Michele Magni; Maurizio Martelli; Massimo Di Nicola; Carmelo Carlo-Stella; Silvana Pilotti; Alessandro Rambaldi; Sergio Cortelazzo; Caterina Patti; Guido Parvis; Fabio Benedetti; Saveria Capria; Paolo Corradini; Corrado Tarella; Tiziano Barbui
Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).
Blood 2003;102(2):749-55.
2003: Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di Nicola; Sergio Cortelazzo; Rosalba Rosato; Carlo Rosanelli; Nicola Di Renzo; Maurizio Musso; Enzo Pavone; Gino Santini; Alessandra Pescarollo; Alberto De Crescenzo; Massimo Federico; Andrea Gallamini; Patrizia Pregno; Roberta Romano; Paolo Coser; Eugenio Gallo; Mario Boccadoro; Tiziano Barbui; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Alessandro Levis
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence.
Cancer 2003;97(11):2748-59.
2003: Ignazio Majolino; Paolo Corradini; Rosanna Scimè; Michele Falda; Alberto Bosi; Corrado Tarella; Maurizio Musso; Attilio Olivieri; Mario Boccadoro; R Marcenò; A Santoro; Alessandro Pileri
High rate of remission and low rate of disease recurrence in patients with multiple myeloma allografted with PBSC from their HLA-identical sibling donors.
Bone marrow transplantation 2003;31(9):767-73.
2003: marco ladetto; Daniela Drandi; Mara Compagno; Monica Astolfi; Federica Volpato; Claudia Voena; Anna Novarino; Berardino Pollio; Alfredo Addeo; Irene Ricca; Patrizia Falco; Federica Cavallo; Sonia Vallet; Paolo Corradini; Alessandro Pileri; Giacomo Tamponi; Antonio Palumbo; Oscar Bertetto; Mario Boccadoro; Corrado Tarella
PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1398-403.
2002: Corrado Tarella; Massimo Di Nicola; Daniele Caracciolo; Francesco Zallio; Alessandra Cuttica; Paola Omedè; P Bondesan; Michele Magni; Paola Matteucci; Andrea Gallamini; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
Bone marrow transplantation 2002;30(11):725-32.
2002: marco ladetto; Paolo Corradini; Sonia Vallet; Fabio Benedetti; Umberto Vitolo; Maurizio Martelli; Maura Brugiatelli; Paolo Coser; Alessio Perrotti; Ignazio Majolino; Giuseppe Fioritoni; Sergio Morandi; Maurizio Musso; Renato Zambello; Teodoro Chisesi; Nicola Di Renzo; Paolo Vivaldi; Alberto De Crescenzo; Andrea Gallamini; Fabrizio Salvi; Gino Santini; Carola Boccomini; Marco Sorio; Monica Astolfi; Daniela Drandi; Alessandro Pileri; Corrado Tarella
High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Blood 2002;100(5):1559-65.
2002: Francesco Zallio; Alessandra Cuttica; Daniele Caracciolo; Paolo Gavarotti; Luciana Bergui; Fulvia Giaretta; P Bondesan; V Tassi; Eugenio Gallo; Alessandro Pileri; Corrado Tarella
Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphoma.
Annals of hematology 2002;81(8):448-53.
2002: Paolo Corradini; Corrado Tarella; Attilio Olivieri; ALESSANDRO MASSIMO GIANNI; Claudia Voena; Francesco Zallio; marco ladetto; Michele Falda; Moira Lucesole; Anna Dodero; Fabio Ciceri; Fabio Benedetti; Alessandro Rambaldi; Maria R Sajeva; Moreno Tresoldi; Alessandro Pileri; Claudio Bordignon; Marco Bregni
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Blood 2002;99(1):75-82.
2001: marco ladetto; Francesco Zallio; Sonia Vallet; Irene Ricca; Alessandra Cuttica; Daniele Caracciolo; Paolo Corradini; Monica Astolfi; Selina Sametti; Federica Volpato; P Bondesan; Umberto Vitolo; Mario Boccadoro; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma.
Leukemia 2001;15(12):1941-9.
2001: cesare guglielmi; Maurizio Martelli; Massimo Federico; Pier Luigi Zinzani; Umberto Vitolo; Giampiero Bellesi; Gino Santini; Corrado Tarella; Francesco Zallio; Patrizia Pregno; Nicola Di Renzo; Luigi Resegotti
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
Haematologica 2001;86(9):941-50.
2001: Sergio Cortelazzo; Alessandro Rambaldi; Andrea Rossi; Elena Oldani; M Ghielmini; F Benedetti; Corrado Tarella; F Zaglio; Umberto Vitolo; Massimo Di Nicola; Enrico Pogliani; Franco Cavalli; ALESSANDRO MASSIMO GIANNI; Tiziano Barbui
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
British journal of haematology 2001;114(2):333-41.
2001: marco ladetto; Selina Sametti; Monica Astolfi; Paolo Corradini; Irene Ricca; Daniela Drandi; Alessandro Pileri; Corrado Tarella
Central nervous system relapse in a patient with mantle cell lymphoma in continuous clinical and molecular remission at six years since autografting.
Leukemia & lymphoma 2001;40(5-6):679-82.
2001: Corrado Tarella; Francesco Zallio; Daniele Caracciolo; Alessandra Cuttica; Paolo Corradini; Paolo Gavarotti; marco ladetto; V Podio; A Sargiotto; G Rossi; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity.
Leukemia 2001;15(2):256-63.
2001: marco ladetto; Selina Sametti; John W Donovan; Dario Ferrero; Monica Astolfi; Manfred Mitterer; Irene Ricca; Daniela Drandi; Paolo Corradini; Paolo Coser; Alessandro Pileri; John G Gribben; Corrado Tarella
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.
Experimental hematology 2001;29(2):183-93.
2001: Corrado Tarella; Alessandra Cuttica; Daniele Caracciolo; Francesco Zallio; Irene Ricca; Luciana Bergui; Paolo Gavarotti; Carlo Marinone; Marco Pagano; G Rossi; Alberto De Crescenzo; A Salomone; marco ladetto; Mario Boccadoro; Alessandro Pileri
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.
Annals of hematology 2001;80 Suppl 3():B123-6.
2000: Corrado Tarella; Daniele Caracciolo; Paolo Gavarotti; C Argentino; Francesco Zallio; Paolo Corradini; Domenico Novero; C Magnani; Alessandro Pileri
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft.
Bone marrow transplantation 2000;26(11):1185-91.
2000: marco ladetto; Luciana Bergui; Irene Ricca; S Campana; Alessandro Pileri; Corrado Tarella
Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients.
Medical oncology (Northwood, London, England) 2000;17(3):203-10.
2000: Michele Magni; Massimo Di Nicola; liliana devizzi; Paola Matteucci; F Lombardi; Lorenza Gandola; Fernando Ravagnani; Roberto Giardini; G Dastoli; Corrado Tarella; Alessandro Pileri; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Blood 2000;96(3):864-9.
2000: Corrado Tarella; Daniele Caracciolo; Paolo Corradini; Francesco Zallio; marco ladetto; Alessandra Cuttica; G Rossi; Domenico Novero; Paolo Gavarotti; Alessandro Pileri
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft.
Leukemia 2000;14(4):740-7.
1999: Paolo Corradini; marco ladetto; Alessandro Pileri; Corrado Tarella
Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategies.
Leukemia 1999;13(11):1691-5.
1999: Mario Boccadoro; Corrado Tarella; Antonio Palumbo; C Argentino; S Triolo; Alida Dominietto; Vincenzo Callea; Vito Michele Lauta; Stefano Molica; Pellegrino Musto; Filippo Marmont; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy.
Haematologica 1999;84(10):905-10.
1999: Corrado Tarella; Paolo Corradini; Monica Astolfi; P Bondesan; Daniele Caracciolo; C Cherasco; marco ladetto; Fulvia Giaretta; Irene Ricca; Umberto Vitolo; Alessandro Pileri; Dario Ferrero
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions.
Leukemia 1999;13(9):1456-62.
1999: Antonio Palumbo; S Triolo; C Argentino; Sara Bringhen; Alida Dominietto; Cecilia Rus; Paola Omedè; Corrado Tarella; Alessandro Pileri; Mario Boccadoro
Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients.
Blood 1999;94(4):1248-53.
1999: Paolo Corradini; Claudia Voena; Corrado Tarella; Monica Astolfi; marco ladetto; Antonio Palumbo; Maria Teresa Van Lint; A Bacigalupo; A Santoro; Maurizio Musso; Ignazio Majolino; Mario Boccadoro; Alessandro Pileri
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):208-15.
1999: Corrado Tarella; Francesco Zallio; Daniele Caracciolo; C Cherasco; P Bondesan; Paolo Gavarotti; Paolo Corradini; V Tassi; Alessandro Pileri
Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients.
Stem cells (Dayton, Ohio) 1999;17(1):55-61.
1998: Ignazio Majolino; Paolo Corradini; Rosanna Scimè; A Santoro; Corrado Tarella; AM Cavallaro; Antonio Palumbo; A Indovina; Daniele Caracciolo; Mario Boccadoro; R Marcenò; Alessandro Pileri
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1998;22(5):449-55.
1998: Dario Ferrero; Corrado Tarella; C Cherasco; P Bondesan; Paola Omedè; R Ravaglia; Daniele Caracciolo; Claudia Castellino; Alessandro Pileri
A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation.
Bone marrow transplantation 1998;21(4):409-13.
1998: Corrado Tarella; Claudia Castellino; Franco Locatelli; Daniele Caracciolo; Paolo Corradini; Michele Falda; Anna Novarino; V Tassi; Alessandro Pileri
G-CSF administration following peripheral blood progenitor cell (PBPC) autograft in lymphoid malignancies: evidence for clinical benefits and reduction of treatment costs.
Bone marrow transplantation 1998;21(4):401-7.
1997: Paola Omedè; Corrado Tarella; Antonio Palumbo; C Argentino; Daniele Caracciolo; Paolo Corradini; Alida Dominietto; Fulvia Giaretta; R Ravaglia; R Triolo; S Triolo; Alessandro Pileri; Mario Boccadoro
Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy courses.
British journal of haematology 1997;99(3):685-91.
1997: Corrado Tarella; Claudia Castellino; C Cherasco; P Bondesan; Fulvia Giaretta; Paolo Corradini; Daniele Caracciolo; Paolo Gavarotti; Alessandro Pileri
Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: comparison with patients at diagnosis and impact on clinical outcome.
British journal of haematology 1997;99(1):41-6.
1997: S Campana; Paolo Corradini; Monica Astolfi; marco ladetto; F Cinque; Domenico Novero; Corrado Tarella; Alessandro Pileri
Analysis of the immunoglobulin heavy-chain gene rearrangement providing molecular evidence of second lymphoma in a patient in apparent relapse after autotransplantation.
Bone marrow transplantation 1997;20(4):341-3.
1997: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; C Brambilla; Massimo Di Nicola; F Lombardi; Lorenza Gandola; Corrado Tarella; Alessandro Pileri; Fernando Ravagnani; Pinuccia Valagussa; Gianni Bonadonna
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
The New England journal of medicine 1997;336(18):1290-7.
1997: Paolo Corradini; Monica Astolfi; C Cherasco; marco ladetto; Claudia Voena; Daniele Caracciolo; Alessandro Pileri; Corrado Tarella
Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografting.
Blood 1997;89(2):724-31.
1996: Massimo Di Nicola; Salvatore Siena; Paolo Corradini; Marco Bregni; Marco Milanesi; Michele Magni; P A Ruffini; Fernando Ravagnani; Corrado Tarella; ALESSANDRO MASSIMO GIANNI
Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system.
Bone marrow transplantation 1996;18(6):1117-21.
1996: Paolo Corradini; marco ladetto; Monica Astolfi; Claudia Voena; Corrado Tarella; A Bacigalupo; Alessandro Pileri
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma.
British journal of haematology 1996;94(2):376-8.
1996: F C Cappio; M Cavo; A DeVincentiis; L Lanuta; Roberto M Lemoli; Ignazio Majolino; Corrado Tarella; P Zanon; Sante Tura
Peripheral blood stem cell transplantation for the treatment of multiple myeloma: biological and clinical implications.
Haematologica 1996;81(4):356-75.
1996: marco ladetto; Paolo Corradini; Monica Astolfi; S Campana; Corrado Tarella; Alessandro Pileri
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia.
Haematologica 1996;81(2):159-61.
1995: Corrado Tarella; G Benedetti; Daniele Caracciolo; Claudia Castellino; C Cherasco; P Bondesan; P Omedé; D Ruggieri; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF.
British journal of haematology 1995;91(3):535-43.
1995: Corrado Tarella; Daniele Caracciolo; Paolo Gavarotti; P Bondesan; C Cherasco; Paola Omedè; Marco Bregni; Salvatore Siena; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization.
Bone marrow transplantation 1995;16(2):223-8.
1995: C C Stella; M Cazzola; Paolo De Fabritiis; A de Vincentiis; ALESSANDRO MASSIMO GIANNI; F Lanza; F Lauria; Roberto M Lemoli; Corrado Tarella; P Zanon
CD34-positive cells: biology and clinical relevance.
Haematologica 1995;80(4):367-87.
1995: Paolo Corradini; Claudia Voena; Monica Astolfi; marco ladetto; Corrado Tarella; Mario Boccadoro; Alessandro Pileri
High-dose sequential chemoradiotherapy in multiple myeloma: residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting.
Blood 1995;85(6):1596-602.
1995: Corrado Tarella; Paolo Gavarotti; Daniele Caracciolo; Paolo Corradini; C Cherasco; Claudia Castellino; E Gallo; Alessandro Pileri
Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rates in poor risk lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6 Suppl 4():3-8.
1994: Salvatore Siena; Marco Bregni; Massimo Di Nicola; F Ravagani; Fedro Alessandro Peccatori; L Gandola; F Lombardi; Corrado Tarella; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(10):935-41.
1994: ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Marco Bregni; Salvatore Siena; F Lombardi; L Gandola; Daniele Caracciolo; A Stern; Gianni Bonadonna; Mario Boccadoro
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):503-9.
1994: G Benedetti; P Bondesan; Daniele Caracciolo; C Cherasco; D Ruggieri; M E Gastaldi; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI; Corrado Tarella
Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
Experimental hematology 1994;22(2):166-73.
1993: Corrado Tarella; Mario Boccadoro; P Omedé; P Bondesan; Daniele Caracciolo; R Frieri; Marco Bregni; Salvatore Siena; ALESSANDRO MASSIMO GIANNI; Alessandro Pileri
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
Bone marrow transplantation 1993;11(4):271-7.
1993: Mario Bazzan; A Pannocchia; Corrado Tarella; S Stella; G Garbarino; Alessandro Pileri; Giacomo Tamponi
Reduction of plasma fibrinolytic activity following high-dose cyclophosphamide is neutralized in vivo by GM-CSF administration.
Haematologica 1993;78(2):105-10.
1992: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; Michele Magni; Massimo Di Nicola; F Lombardi; Corrado Tarella; A Pileri; Gianni Bonadonna
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1955-62.
1992: Corrado Tarella; Paola Omedè; Mario Boccadoro; Antonio Palumbo; Silvano Battaglio; Alessandro Pileri
Early disappearance of murine plasmocytoma stem cells in long-term bone marrow culture.
Leukemia research 1992;16(8):743-50.
1991: Marilena Bertini; Lorella Orsucci; Umberto Vitolo; A Levis; Giuseppe Todeschini; Vittorio Meneghini; Domenico Novero; Corrado Tarella; E Gallo; G Luxi
Stage II large B-cell lymphoma with sclerosis treated with MACOP-B.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(10):733-7.
1991: Corrado Tarella; Dario Ferrero; Marco Bregni; Salvatore Siena; E Gallo; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF.
European journal of cancer (Oxford, England : 1990) 1991;27(1):22-7.
1991: Luigi Resegotti; Umberto Vitolo; Marilena Bertini; Ercole Brusamolino; B Comotti; Corrado Tarella; Giuseppe Todeschini; M Aglietta; T Barbui; C Bernasconi
MACOP-B for advanced stage large cell lymphoma (DLCL). More is better? Italian Multiregional Cooperative Study Group (IMCSGL).
Leukemia 1991;5 Suppl 1():86-9.
1990: ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Salvatore Siena; Marco Bregni; Mario Boccadoro; F Lombardi; C Bengala; Gianni Bonadonna; A Pileri
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells.
Bone marrow transplantation 1990;6(2):143-5.
1990: Daniele Caracciolo; A Pannocchia; S Treves; Dario Ghigo; E Gallo; Corrado Tarella; Federico Bussolino; Franco Turrini; Giacomo Tamponi; Amalia Bosia
Role of Na+/H+ exchange in the granulocyte-macrophage colony-stimulating factor-dependent growth of a leukemic cell line.
Journal of cellular physiology 1990;143(1):133-9.
1990: Corrado Tarella; E Gallo; Dario Ferrero; R Badoni; N Carlesso; Daniele Caracciolo; Alessandro Pileri
MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse.
Haematologica 1990;75(2):149-54.
1990: Corrado Tarella; Dario Ferrero; Salvatore Siena; E Gallo; P Bondesan; Marco Bregni; Alessandro Pileri; ALESSANDRO MASSIMO GIANNI
Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment.
Haematologica 1990;75 Suppl 1():11-4.
1990: Corrado Tarella; Patrizia Pregno; E Gallo; Daniele Caracciolo; S Stefani; C Barletta; Luisa Lanfrancone; Dario Ferrero
Establishment from an adult leukemic patient of two novel precursor B cell lines with different growth modality.
Leukemia research 1990;14(2):177-84.
1990: Salvatore Siena; Marco Bregni; Fernando Ravagnani; B Brando; Corrado Tarella; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF).
Haematologica 1990;75 Suppl 1():6-10.
1990: Corrado Tarella; Paolo Gavarotti; Daniele Caracciolo; Franco Locatelli; Michele Falda; F Paolino; Elisabetta Lovisone; E Sormano; V Tassi; A Urgesi
Use of peripheral blood stem cells to accelerate hemopoietic recovery following autologous bone marrow transplantation.
Haematologica 1990;75 Suppl 1():90-4.
1990: Alessandro Pileri; Corrado Tarella; Marco Bregni; Mario Boccadoro; Salvatore Siena; Daniele Caracciolo; G Bonadonna; ALESSANDRO MASSIMO GIANNI
GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myeloma.
Haematologica 1990;75 Suppl 1():79-82.
1989: Paolo De Fabritiis; Dario Ferrero; A Sandrelli; Corrado Tarella; Giovanna Meloni; Alessandro Pulsoni; Patrizia Pregno; R Badoni; Lidia De Felice; E Gallo
Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
Bone marrow transplantation 1989;4(6):669-74.
1989: Umberto Vitolo; Marilena Bertini; Corrado Tarella; M C Bertoncelli; Andrea Gallamini; E Gallo; A M Gatti; Riccardo Ghio; A Levis; G Luxi
MACOP-B treatment for advanced stage diffuse large cell lymphoma: a multicenter Italian Study.
European journal of cancer & clinical oncology 1989;25(10):1441-9.
1989: Dario Ferrero; Corrado Tarella; R Badoni; Daniele Caracciolo; Graziella Bellone; Alessandro Pileri; E Gallo
Granulocyte-macrophage colony-stimulating factor requires interaction with accessory cells or granulocyte-colony stimulating factor for full stimulation of human myeloid progenitors.
Blood 1989;73(2):402-5.
1988: Corrado Tarella; Dario Ferrero; Daniele Caracciolo; R Badoni; Graziella Bellone; E Gallo
Immunological separation of two CFU-GM subsets showing different responsiveness to T-cell derived growth factors.
Journal of clinical & laboratory immunology 1988;25(4):185-90.
1987: Dario Ferrero; Patrizia Pregno; Corrado Tarella; F W Ruscetti; Alessandro Pileri; E Gallo
Trophoblast cell line conditioned medium for in vitro culture and antigenic characterization of acute myeloid leukemia clonogenic cells.
Cancer research 1987;47(23):6413-7.
1987: Dario Ferrero; Paolo De Fabritiis; Sergio Amadori; Lidia De Felice; E Gallo; G Meloni; Patrizia Pregno; Alessandro Pulsoni; F Simone; Corrado Tarella
Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement.
Leukemia research 1987;11(3):265-72.
1986: Dario Ferrero; Corrado Tarella; Patrizia Pregno; Alessandro Pileri; E Gallo
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
Cancer research 1986;46(2):975-80.
1985: Luisa Lanfrancone; Dario Ferrero; E Gallo; R Foa; Corrado Tarella
Release of hemopoietic factors by normal human T cell lines with either suppressor or helper activity.
Journal of cellular physiology 1985;122(1):7-13.